AppLovin
APP
$228.50
-10.36%
AppLovin is a vertically integrated advertising technology company operating in the mobile app marketing and monetization space, running a demand-side platform (AppDiscovery) for advertisers, a supply-side platform (Max) for publishers, and an exchange connecting the two, with roughly 80% of revenue generated by the DSP. Its competitive identity rests on Axon 2, a machine-learning ad optimizer that lets advertisers bid against specified return thresholds, positioning AppLovin less as a conventional ad network and more as an AI-driven performance-marketing engine with software-like margins. The current investor narrative is sharply polarized: bulls point to a Rule-of-40 profile competitive with the best software names, blistering revenue growth and 60%+ net margins, while bears focus on decelerating growth optics, competitive encroachment from Meta and AI-native ad tools, and a brutal share-price collapse that has erased more than half of the stock's value over the past year. A high-profile downgrade and a string of cautious analyst moves have amplified the debate over whether the selloff represents a generational entry point or a structural de-rating of the ad-tech growth premium.…
APP
AppLovin
$228.50
Related headlines
APP 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AppLovin's 12-month outlook, with a consensus price target around $452.95 and implied upside of +98.2% versus the current price.
Average Target
$452.95
0 analysts
Implied Upside
+98.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$325 - $625
Analyst target range
Coverage is broad and institutional, with 31 analysts and a consensus recommendation of "buy" (mean rating 1.576 on a 1-to-5 scale where 1 is strong buy). The average target price of $476.85 implies roughly +83.2% upside from the current $260.25, a spread that is unusually wide and signals that the selloff has outrun fundamental estimates. Consensus 2026 EPS of $29.78 and revenue of $15.21 billion (range $14.15 billion to $16.37 billion) underpin the bullish case, and the consensus clearly leans bullish despite the price collapse.
The target range spans $325 to $790 — a low target still 24.9% above the current price and a high target implying roughly 3x upside — a dispersion of more than 2.4x that signals very high uncertainty and low conviction in point estimates. The high target likely assumes multiple re-expansion toward historical PS levels alongside continued 50%+ growth and Axon 2 share gains, while the low target prices in competitive share loss to Meta and AI-native platforms plus margin compression. Recent institutional actions skew cautious: B of A Securities downgraded from Buy to Neutral on August 11, 2026, while Piper Sandler and Wells Fargo maintain Neutral/Equal Weight stances; Morgan Stanley, BTIG, Evercore ISI, Needham, Benchmark, and Citigroup remain constructive with Buy/Overweight/Outperform ratings. The pattern of reiterated rather than raised ratings, combined with the wide target spread, suggests analysts are holding their fundamental views while the market reprices risk — a setup that historically resolves either through a violent mean-reversion rally or through estimate cuts that validate the bear case.
Bulls vs Bears: APP Investment Factors
The evidence is genuinely two-sided, but the fundamental side currently carries more weight: 52.82% revenue growth, 65.8% net margins, $4.5B TTM free cash flow, and a 12.7x forward PE are objectively strong, and the analyst consensus of 'buy' with an $476.85 average target implies 83% upside. The bear case rests less on deteriorating fundamentals than on price action — a -64.52% max drawdown, -69.00% one-year relative strength, and a stock pinned at 0.4% of its 52-week range — plus a B of A downgrade and competitive noise from Meta. The single most important tension is the gap between the 68.5x trailing and 12.68x forward PE: either the market is mispricing a visible earnings ramp (consensus EPS $29.78), or the forward estimate embeds assumptions the market is rejecting. How that resolves — through delivered earnings or through estimate cuts — will determine whether this is a generational entry point or a structural de-rating.
Bullish
- Revenue re-accelerating above 50%: Q2 2026 revenue of $1.924B grew 52.82% YoY, up from $1.259B in Q2 2025, and has risen sequentially for five straight quarters ($1.259B → $1.405B → $1.658B → $1.842B → $1.924B). The acceleration from high-40s to low-50s growth directly contradicts the deceleration narrative driving the selloff.
- Elite 65.8% net margin, 88.3% gross margin: Q2 2026 net income of $1.267B on $1.924B revenue equals a 65.8% net margin, with gross margin at 88.26% and operating margin at 77.68%. Margins have expanded, not compressed — net margin rose from 65.1% in Q2 2025 to 65.8%, undermining the thesis that AI disruption is already eroding economics.
- Forward PE of 12.7x vs 68.5x trailing: The 81% compression between trailing PE (68.5x) and forward PE (12.68x) on consensus EPS of $29.78 implies the market is pricing a hyper-growth earnings ramp at a deep discount. A PEG of 0.62 for a company growing revenue above 50% is strikingly low.
- Analyst target implies 83% upside: 31 analysts carry a consensus 'buy' (mean 1.576) with an average target of $476.85, roughly +83.2% from $260.25. Even the low target of $325 sits 24.9% above the current price, suggesting the selloff has outrun fundamental estimates.
Bearish
- Falling knife: 0.4% of 52-week range: At $260.25 the stock sits just 0.7% above its 52-week low of $258.32 and 64.7% below the $738.01 high, with a max drawdown of -64.52%. Momentum is accelerating downward — -17.45% in one month, -33.61% in three, -41.95% in six — a classic distribution pattern.
- Severe relative strength deterioration: One-year relative strength versus SPY is -69.00% and one-month is -16.43%, while the stock is down 57.91% YTD against SPY's +11.45%. The widening divergence signals institutional de-risking rather than a temporary mean-reversion wobble.
- Valuation still rich on trailing metrics: Despite the collapse, PS is 41.65x, P/B is 106.9x, EV/EBITDA is 52.7x, and price-to-FCF is 57.5x. The 12.7x forward PE depends entirely on consensus EPS of $29.78 materializing — a figure the price action is actively rejecting.
- Beta of 2.56 amplifies downside: With a beta of 2.557, a 1% SPY move implies roughly a 2.6% move in APP, and the stock already carries a -64.52% realized drawdown. Position sizing must account for gap risk around earnings and rating changes.
APP Technical Analysis
AppLovin is locked in a severe, sustained downtrend, with the stock down 55.87% over the trailing year and 57.91% year-to-date, dramatically underperforming the S&P 500's +13.13% and +11.45% respective returns. At $260.25, the shares sit just 0.7% above their 52-week low of $258.32 and roughly 64.7% below the 52-week high of $738.01, placing the stock at approximately 0.4% of its 52-week range — a positioning that signals persistent distribution and momentum-driven selling rather than a healthy pullback, and raises the risk of a falling-knife dynamic for anyone attempting to catch the bottom. The maximum drawdown of -64.52% confirms the scale of the de-rating.
Short-term momentum is unambiguously negative and accelerating to the downside: the stock is down 17.45% over the past month, 33.61% over three months, and 41.95% over six months, with each successive window showing deeper losses than the prior one. The 1-month relative strength versus SPY is -16.43%, and the 1-year relative strength is a staggering -69.00%, meaning the divergence from the broader market is widening rather than converging — a classic signature of institutional de-risking rather than a temporary mean-reversion wobble. The most recent session saw a further -1.52% decline on volume of roughly 2.31 million shares, indicating selling pressure remains active into the lows rather than exhausting.
Key technical levels are now starkly defined: the 52-week low at $258.32 is the immediate support shelf, and a decisive breakdown below it would likely trigger another leg of momentum selling and open air beneath the stock, while the 52-week high at $738.01 represents a distant resistance level that would require a near-tripling to reclaim. With a beta of 2.557, AppLovin is roughly 2.6 times as volatile as the market, meaning position sizing must account for the fact that a 1% SPY move implies roughly a 2.6% move here — a critical consideration given the stock's already-elevated realized drawdown and the elevated risk of gap moves around earnings or rating changes.
Beta
2.56
2.56x market volatility
Max Drawdown
-68.8%
Largest decline past year
52-Week Range
$225-$738
Price range past year
Annual Return
-63.2%
Cumulative gain past year
| Period | APP Return | S&P 500 |
|---|---|---|
| 1m | -21.3% | -0.9% |
| 3m | -42.3% | +1.2% |
| 6m | -50.3% | +4.9% |
| 1y | -63.2% | +11.2% |
| ytd | -63.0% | +10.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
APP Fundamental Analysis
The revenue trajectory remains exceptional even as the stock collapses: Q2 2026 revenue reached $1.924 billion, up 52.82% year-over-year, building on a clear multi-quarter acceleration from $1.259 billion in Q2 2025, $1.405 billion in Q3 2025, $1.658 billion in Q4 2025, and $1.842 billion in Q1 2026. Sequentially, revenue has grown every quarter for the past five periods, and the year-over-year growth rate has re-accelerated from the high-40s into the low-50s, underscoring that the core DSP engine remains robust despite competitive noise. The entire reported revenue base flows through a single reportable segment, so there is no segment-level dilution of the growth story — the investment case hinges almost entirely on the durability of AppDiscovery and Axon 2 monetization.
Profitability is elite by any software standard: Q2 2026 net income was $1.267 billion on $1.924 billion of revenue, a 65.8% net margin, with gross margin at 88.26% and operating margin at 77.68%. Margins have been remarkably stable-to-expanding across the trailing five quarters — gross margin moved from 87.68% in Q2 2025 to 88.26% in Q2 2026, while net margin climbed from 65.1% to 65.8% over the same span, and EBITDA margin sits near 80.9%. This is a business converting revenue into profit at rates that rival the best pure-play software franchises, and the consistency argues against the thesis that AI disruption is already compressing economics.
Balance-sheet and cash-flow metrics are similarly strong: free cash flow TTM stands at $4.499 billion, Q2 2026 operating cash flow was $869 million, and the company held $3.053 billion in cash at quarter-end against a current ratio of 3.32 and a debt-to-equity ratio of 1.66. ROE of 156.2% and ROA of 46.5% reflect both genuine profitability and a leveraged capital structure, while interest coverage of roughly 29x on $51.2 million of quarterly interest expense leaves ample cushion. The company is aggressively returning capital — $551.2 million of buybacks in Q2 2026 and $981.7 million in Q1 2026 — funded entirely from internal cash generation, which underscores that AppLovin does not depend on external financing to fund growth.
Quarterly Revenue
$1.9B
2026-06
Revenue YoY Growth
+52.8%
YoY Comparison
Gross Margin
88.3%
Latest Quarter
Free Cash Flow
$4.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is APP Overvalued?
Because AppLovin is solidly profitable (Q2 2026 net income of $1.267 billion), the PE ratio is the appropriate primary metric. The trailing PE stands at 68.5x, but the forward PE is just 12.68x — an extraordinary 81% compression that implies the market expects earnings to multiply over the next twelve months, consistent with consensus EPS estimates of $29.78 versus the trailing figure. The gap between trailing and forward multiples is the single most important valuation signal in this dataset: either the market is mispricing a hyper-growth earnings ramp, or the forward estimate embeds assumptions the stock's price action is actively rejecting.
Relative to its own history, the stock has de-rated violently: the PE ratio was 106.7x at year-end 2025, 72.7x in Q3 2025, and 51.7x in Q4 2025, versus 68.5x today on trailing earnings — but the more telling comparison is the PS ratio, which has collapsed from 173.1x in Q3 2025 to 41.65x currently, and the price-to-free-cash-flow ratio, which has fallen from 230.9x to 57.5x over the same period. On a PEG basis, the 0.62 ratio is strikingly low for a company growing revenue above 50%, suggesting the market is pricing in severe deceleration or margin risk. Peer comparison data for the software-application industry average is not available in the provided dataset, so a precise premium/discount spread cannot be quantified, but the combination of a 41.7x PS, 106.9x P/B, and 52.7x EV/EBITDA against a 12.7x forward PE frames a stock priced for perfection on trailing metrics yet cheap on forward earnings — a contradiction that reflects deep uncertainty about the durability of the growth trajectory.
PE
68.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 20x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
52.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on concentration and the dependence of the valuation on a forward earnings ramp. Roughly 80% of revenue comes from a single DSP product (AppDiscovery), and the entire reported revenue base flows through one reportable segment, so any Axon 2 monetization stumble hits the whole thesis. The forward PE of 12.68x versus 68.5x trailing requires EPS to roughly quintuple toward the $29.78 consensus; if growth decelerates from 52.82%, the multiple math breaks. Debt-to-equity of 1.66 and $51.2M quarterly interest expense are manageable at ~29x coverage, but ROE of 156.2% is partly a leverage artifact, and the $4.499B TTM FCF must keep funding both $1.5B+ of annual buybacks and growth investment.
Market and competitive risks are dominated by valuation compression and share loss. Even after a -64.52% drawdown, PS of 41.65x, P/B of 106.9x, and EV/EBITDA of 52.7x leave little room for error, and the PS ratio has already collapsed from 173.1x in Q3 2025 — a de-rating that may not be finished. Meta and AI-native ad tools are encroaching on performance marketing, and the B of A downgrade to Neutral on August 11, 2026, alongside Neutral stances at Piper Sandler and Wells Fargo, shows sell-side conviction fraying. With a beta of 2.557, macro risk-off episodes hit APP roughly 2.6x the market, and the -69.00% one-year relative strength versus SPY confirms sector rotation is already punishing the name.
Worst-case scenario: Q3 2026 results miss consensus, management guides revenue growth below 40%, and analysts cut the $29.78 EPS estimate, collapsing the forward-PE support. That chain would likely break the $258.32 52-week low, opening air beneath the stock toward the $325 analyst low only after further downside — a realistic adverse path is a retest and break of $258.32, implying roughly -35% to -40% from $260.25 toward the $155–$170 zone if the -64.52% max drawdown pattern repeats from the $738.01 high. Even the analyst low target of $325 is above the current price, meaning the sell-side has no downside anchor here; the 52-week low is the only technical floor, and it is 0.7% away.